SLC22A3 and renal cell carcinoma: Shinatsar et al. investigated mRNA expression levels of some members of the SLCA22A family in renal cell carcinoma cell lines and reported that expression of SLC22A3 increases the chemosensitivity to some drugs in kidney carcinoma cell lines [29].